Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 

Slides:



Advertisements
Similar presentations
Volume 68, Issue 5, Pages (November 2005)
Advertisements

Stephen P. McDonald, Graeme R. Russ  Kidney International 
Hypothesis: an erythropoietin honeymoon phase exists
Volume 62, Issue 6, Pages (December 2002)
LDL cholesterol in CKD—to treat or not to treat?
Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Volume 74, Issue 9, Pages (November 2008)
Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh  Kidney International 
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
End-stage renal disease in developing countries
Volume 83, Issue 3, Pages (March 2013)
Volume 68, Issue 5, Pages (November 2005)
Stem cells for kidney repair: useful tool for acute renal failure?
Volume 75, Issue 3, Pages (February 2009)
Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh  Kidney International 
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target  Szu-Chun Hung, Der-Cherng Tarng  Kidney International 
Prehypertension and chronic kidney disease: the ox or the plow?
Continuous renal replacement therapy in the critically ill patient
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
The risk of hospitalization and modality failure with home dialysis
John P. Middleton, Patrick H. Pun  Kidney International 
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Need for better diabetes treatment for improved renal outcome
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Metformin and other antidiabetic agents in renal failure patients
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Anemia as a risk factor for chronic kidney disease
Comorbidity and confounding in end-stage renal disease
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Renal risk scores: Progress and prospects
Volume 62, Issue 6, Pages (December 2002)
Use of vitamin D in chronic kidney disease patients
Volume 87, Issue 2, Pages (February 2015)
LDL cholesterol in CKD—to treat or not to treat?
Volume 86, Issue 1, Pages (July 2014)
Kenar D. Jhaveri, Steven Fishbane  Kidney International 
Fructose intake as a risk factor for kidney stone disease
Volume 73, Issue 12, Pages (June 2008)
Volume 76, Issue 6, Pages (September 2009)
A physician's perseverance uncovers problems in a key nephrology study
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Elevated risk of stroke among patients with end-stage renal disease
Volume 87, Issue 1, Pages (January 2015)
Volume 76, Issue 8, Pages (October 2009)
V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen 
Volume 80, Issue 6, Pages (September 2011)
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Volume 85, Issue 5, Pages (May 2014)
Vitamin D in chronic kidney disease: is the jury in?
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Volume 64, Issue 2, Pages (August 2003)
Cardio-Kidney-Damage: a unifying concept
Does equal care give equal outcomes?
The Iranian model of living renal transplantation
The Danish Renal Biopsy Register
Volume 80, Issue 10, Pages (November 2011)
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Volume 75, Issue 1, Pages (January 2009)
Is complement a target for therapy in renal disease?
Changes to the End-Stage Renal Disease Quality Incentive Program
Volume 87, Issue 3, Pages (March 2015)
The International Pediatric Peritonitis Registry: Starting to walk
Antioxidant therapy in hemodialysis patients: a systematic review
Presentation transcript:

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International  Volume 77, Issue 3, Pages 175-177 (February 2010) DOI: 10.1038/ki.2009.455 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Hospitalizations for congestive heart failure (without renal replacement therapy) in the CHOIR study. There was a strong trend (hazard ratio 1.41, P=0.07) toward increased risk for hospitalization among patients randomized to the high-hemoglobin-target group. (Adapted with permission from ref. 2.) Kidney International 2010 77, 175-177DOI: (10.1038/ki.2009.455) Copyright © 2010 International Society of Nephrology Terms and Conditions